Search

Results: 2

Stratification and therapeutic potential of PML in metastatic breast cancer.

Natalia Martín-Martín, Marco Piva, Jelena Urosevic, Paula Aldaz, James D Sutherland, Sonia Fernández-Ruiz, Leire Arreal, Verónica Torrano, Ana R Cortazar, Evarist Planet, Marc Guiu, Nina Radosevic-Robin, Stephane Garcia, Iratxe Macías, Fernando Salvador, Giacomo Domenici, Oscar M Rueda, Amaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Patricia Zúñiga-García, Alfredo Caro-Maldonado, Lorea Valcárcel-Jiménez, Pilar Sánchez-Mosquera, Marta Varela-Rey, Maria Luz Martínez-Chantar, Juan Anguita, Yasir H Ibrahim, Maurizio Scaltriti, Charles H Lawrie, Ana M Aransay, Juan L Iovanna, Jose Baselga, Carlos Caldas, Rosa Barrio, Violeta Serra, Maria dM Vivanco, Ander Matheu, Roger R Gomis, Arkaitz Carracedo

Aug 24, 2016

Animals Arsenic Trioxide Arsenicals Breast Neoplasms Cell Line Tumor Female Gene Knockdown Techniques Humans MCF-7 Cells Mice Neoplasm Invasiveness Oxides Promoter Regions Genetic Promyelocytic Leukemia Protein SOX9 Transcription Factor STAT3 Transcription Factor Xenograft Model Antitumor Assays

Published by:

View Article

Acetarsol Suppositories

Christopher J Kiely, Angela Clark, Joya Bhattacharyya, Gordon W Moran, James C Lee, Miles Parkes

Mar 02, 2018

BACKGROUND: Management of proctitis refractory to conventional therapies presents a common clinical problem. The use of acetarsol suppositories, which are derived from organic arsenic, was first described in 1965. Data...

Acetarsol Crohn’s Disease inflammatory bowel disease Proctitis Ulcerative colitis Adult Anti-Infective Agents Arsenicals Female Humans Inflammatory Bowel Diseases Male Middle Aged Proctitis Retrospective Studies Suppositories Treatment Outcome Young Adult

Published by: